CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

SEBI issues directive to publish detailed COVID-19 impact
Pratik Shastri
/ Categories: Trending, DSIJ News

SEBI issues directive to publish detailed COVID-19 impact

A directive requiring listed companies to disclose details of the hit taken by their businesses due to COVID-19, was issued by stock market regulator, Securities and Exchange board of India (SEBI).

In its directive, SEBI claimed that many firms obligated under Listing Obligations and Disclosure Requirements (LODR) had only partially disclosed material impacts of the lockdown situation due to coronavirus. It has accordingly issued this direction to ensure that all the investors can receive adequate and updated information to help them assess their standing.

The listed companies have, thereafter, started evaluating and presenting respective disclosures, both qualitatively and quantitatively, in compliance with the new directive.

Various parameters to be given importance in such evaluations comprise impacts on profits, liquidity and debt service, capital adequacy and resources, supply chain, demand and supply situation, internal financial controls, existing contracts etc.

A negative hit on annual revenues of nearly 40 per cent is visible in these companies, based on examination of the disclosures. Moreover, the net impact on sales demand is expected to remain low despite the production capacities commencing work at more than 50 per cent utilization rates.

Previous Article Sun Pharma partners with SPARC to treat skin conditions
Next Article D-Street likely to start on a negative note
Print
954 Rate this article:
5.0
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR